md asaduzzaman khan
Boston University
Boston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Editors
Review Editors
mohammad imran khan
King Abdulaziz University
Jeddah, Saudi Arabia
Review Editor
Pharmacology of Anti-Cancer Drugs
sajid khan
The University of Texas Health Science Center at San Antonio
San Antonio, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
shafiq khan
Clark Atlanta University
Atlanta, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
vishwa khare
Eurofins Viracor
Lee's Summit, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
muhammad rizwan khawaja
HonorHealth (United States)
Scottsdale, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
rahul khupse
University of Findlay
Findlay, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
do-hee kim
Kyonggi University
Suwon, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
hyung sik kim
Sungkyunkwan University
Jongno-gu, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
akiko kimura
Takeda (Japan)
Osaka, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
carl michael kirkpatrick
Monash University
Melbourne, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
jerome kluza
Université de Lille
Lille, France
Review Editor
Pharmacology of Anti-Cancer Drugs
jayaprakash n kolla
Institute of Molecular Genetics (ASCR)
Prague, Czechia
Review Editor
Pharmacology of Anti-Cancer Drugs
dana-lynn koomoa-lange
Western New England University
Springfield, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
anand krishnan
University of the Free State
Bloemfontein, South Africa
Review Editor
Pharmacology of Anti-Cancer Drugs
olga krysko
Ghent University
Ghent, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs